Molecular epidemiology and evolution of human respiratory syncytial virus and human metapneumovirus

PLoS ONE

Volumn 6, Issue 3, 2011, Pages

  Gaunt, Eleanor R ^a   Jansen, Rogier R ^b   Poovorawan, Yong ^c   Templeton, Kate E ^e   Toms, Geoffrey L ^d   Simmonds, Peter ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c CHULALONGKORN UNIVERSITY   (Thailand)

^d NEWCASTLE UNIVERSITY   (United Kingdom)

^e ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; VIRUS FUSION PROTEIN; VIRUS GLYCOPROTEIN; VIRUS PROTEIN;

ARTICLE; CLADISTICS; GENE FREQUENCY; GENETIC VARIABILITY; HUMAN METAPNEUMOVIRUS; IMMUNE RESPONSE; MOLECULAR EPIDEMIOLOGY; MOLECULAR EVOLUTION; NETHERLANDS; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; THAILAND; UNINDEXED SEQUENCE; UNITED KINGDOM; VIRAL GENETICS; AMINO ACID SUBSTITUTION; GENETIC SELECTION; GENETICS; HUMAN; METABOLISM; METAPNEUMOVIRUS; PARAMYXOVIRUS INFECTION; RESPIRATORY SYNCYTIAL VIRUS INFECTION; VIRUS GENE;

HUMAN METAPNEUMOVIRUS; HUMAN RESPIRATORY SYNCYTIAL VIRUS; HYDRANGEA RINGSPOT VIRUS; PARAMYXOVIRIDAE; PNEUMOVIRINAE;

AMINO ACID SUBSTITUTION; BASE SEQUENCE; EVOLUTION, MOLECULAR; GENES, VIRAL; HUMANS; METAPNEUMOVIRUS; PARAMYXOVIRIDAE INFECTIONS; PHYLOGENY; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; SELECTION, GENETIC; VIRAL PROTEINS;

EID: 79952302080     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0017427     Document Type: Article

References (79)

1. Anderson LJ, Hierholzer JC, Tsou C, Hendry RM, Fernie BF, et al. (1985) Antigenic characterization of respiratory syncytial virus strains with monoclonal antibodies. J Inf Dis 151 (4): 626-633.
2. Mufson MA, Orvell C, Rafnar B, Norrby E, (1985) Two distinct subtypes of human respiratory syncytial virus. J Gen Virol 66 (10): 2111-2124.
3. van den Hoogen BG, de Jong JC, Groen J, Kuiken T, de Groot R, et al. (2001) A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat Med 7: 719-724.
4. McGill A, Greensill J, Marsh R, Craft AW, Toms GL, (2004) Detection of human respiratory syncytial virus genotype specific antibody responses in infants. J Med Virol 74 (3): 492-498.
5. Venter M, Madhi SA, Tiemessen CT, Schoub BD, (2001) Genetic diversity and molecular epidemiology of respiratory syncytial virus over four consecutive seasons in South Africa: identification of new subgroup A and B genotypes. J Gen Virol 82 (9): 2117-2124.
6. Morgan LA, Routledge EG, Willcocks MM, Samson ACR, Scott R, et al. (1987) Strain variation of respiratory syncytial virus. J Gen Virol 68 (11): 2781-2788.
7. Taylor CE, Morrow S, Scott M, Young B, Toms GL, (1989) Comparative virulence of respiratory syncytial virus subgroups A and B. Lancet 333 (8641): 777-778.
8. Cane PA, Matthews DA, Pringle CR, (1994) Analysis of respiratory syncytial virus strain variation in successive epidemics in one city. J Clin Microbiol 32 (1): 1-4.
9. Peret T, Hall C, Hammond G, Piedra P, Storch G, et al. (2000) Circulation patterns of group A and B human respiratory syncytial virus genotypes in 5 communities in North America. J Inf Dis 181 (6): 1891-1896.
10. Zlateva KT, Lemey P, Vandamme AM, Van Ranst M, (2004) Molecular evolution and circulation patterns of human respiratory syncytial virus subgroup A: positively selected sites in the attachment G glycoprotein. J Virol 78 (9): 4675-4683.
11. Zlateva KT, Lemey P, Moes E, Vandamme AM, Van Ranst M, (2005) Genetic variability and molecular evolution of the human respiratory syncytial virus subgroup B attachment G protein. J Virol 79 (14): 9157-9167.
12. Agapov E, Sumino KAC, Gaudreaultâ-Keener M, Storch GAA, Holtzman MAJ, (2006) Genetic variability of human metapneumovirus infection: evidence of a shift in viral genotype without a change in illness. J Inf Dis 193 (3): 396-403.
13. Gaunt E, McWilliam-Leitch EC, Templeton K, Simmonds P, (2009) Incidence, molecular epidemiology and clinical presentations of human metapneumovirus; assessment of its importance as a diagnostic screening target. J Clin Virol 46 (4): 318-324.
14. Åkerlind B, Norrby E, (1986) Occurrence of respiratory syncytial virus subtypes a and b strains in sweden. J Med Virol 19 (3): 241-247.
15. Deng J, Qian Y, Zhu RN, Wang F, Zhao LQ, (2006) Surveillance for respiratory syncytial virus subtypes A and B in children with acute respiratory infections in Beijing during 2000 to 2006 seasons [Article in Chinese]. Zhonghua Er Ke Za Zhi 44 (12): 924-7.
16. Hendry RM, Pierik LT, McIntosh K, (1989) Prevalence of respiratory syncytial virus subgroups over six consecutive outbreaks: 1981-1987. J Inf Dis 160 (2): 185-190.
17. Mufson MA, Belshe RB, Orvell C, Norrby E, (1988) Respiratory syncytial virus epidemics: variable dominance of subgroups A and B strains among children, 1981-1986. J Inf Dis 157 (1): 143-8.
18. Freymuth F, Petitjean J, Pothier P, Brouard J, Norrby E, (1991) Prevalence of respiratory syncytial virus subgroups A and B in France from 1982 to 1990. J Clin Microbiol 29 (3): 653-655.
19. Monto AS, Ohmit S, (1990) Respiratory syncytial virus in a community population: circulation of subgroups A and B since 1965. J Inf Dis 161 (4): 781-783.
20. Zlateva KT, Vijgen L, Dekeersmaeker N, Naranjo C, Van Ranst M, (2007) Subgroup prevalence and genotype circulation patterns of human respiratory syncytial virus in Belgium during 10 successive epidemic seasons. J Clin Microbiol pp. JCM.00339-07.
21. Matsuzaki Y, Itagaki T, Abiko C, Aoki Y, Suto A, et al. (2008) Clinical impact of human metapneumovirus genotypes and genotype-specific seroprevalence in Yamagata, Japan. J Med Virol 80 (6): 1084-9.
22. Vicente D, Montes M, Cilla G, Perez-Yarza EG, Perez-Trallero E, (2006) Differences in clinical severity between genotype A and genotype B human metapneumovirus infection in children. Clin Inf Dis 42 (12): e111-3.
23. Bastien N, Ward D, Van Caeseele P, Brandt K, Lee SHS, et al. (2003) Human metapneumovirus infection in the Canadian population. J Clin Microbiol 41 (10): 4642-4646.
24. Boivin G, Abed Y, Pelletier G, Ruel L, Moisan D, et al. (2002) Virological features and clinical manifestations associated with human metapneumovirus: a new paramyxovirus responsible for acute respiratory tract infections in all age groups. J Inf Dis 186 (9): 1330-1334.
25. Esper F, Boucher D, Weibel C, Martinello RA, Kahn JS, (2003) Human metapneumovirus infection in the United States: clinical manifestations associated with a newly emerging respiratory infection in children. Pediatrics 111 (6): 1407-1410.
26. Falsey AR, Erdman D, Anderson LJ, Walsh EE, (2003) Human metapneumovirus infections in young and elderly adults. J Inf Dis 187 (5): 785-790.
27. Stockton J, Stephenson I, Fleming D, Zambon M, (2002) Human metapneumovirus as a cause of community-acquired respiratory illness. Emerg Inf Dis 8 (9): 897-901.
28. Hendry RM, Burns JC, Walsh EE, Graham BS, Wright PF, et al. (1988) Strain-specific serum antibody responses in infants undergoing primary infection with respiratory syncytial virus. J Inf Dis 157 (4): 640-647.
29. Olmsted RA, Elango N, Prince GA, Murphy BR, Johnson PR, et al. (1986) Expression of the F glycoprotein of respiratory syncytial virus by a recombinant vaccinia virus: comparison of the individual contributions of the F and G glycoproteins to host immunity. Proc Nat Acad Sci USA 83 (19): 7462-7466.
30. Endo R, Ebihara T, Ishiguro N, Teramoto S, Ariga T, et al. (2008) Detection of four genetic subgroup-specific antibodies to human metapneumovirus attachment (G) protein in human serum. J Gen Virol 89 (8): 1970-1977.
31. Skiadopoulos MH, Biacchesi S, Buchholz UJ, Riggs JM, Surman SR, et al. (2004) The two major human metapneumovirus genetic lineages are highly related antigenically, and the fusion (F) protein is a major contributor to this antigenic relatedness. J Virol 78 (13): 6927-6937.
32. van den Hoogen BG, Herfst S, de Graaf M, Sprong L, van Lavieren R, et al. (2007) Experimental infection of macaques with human metapneumovirus induces transient protective immunity. J Gen Virol 88 (4): 1251-1259.
33. Herfst S, de Graaf M, Schrauwen EJA, Ulbrandt ND, Barnes AS, et al. (2007) Immunization of Syrian golden hamsters with F subunit vaccine of human metapneumovirus induces protection against challenge with homologous or heterologous strains. J Gen Virol 88 (10): 2702-2709.
34. Hernandez LD, Hoffman LR, Wolfsberg TG, White JM, (1996) Virus-cell and cell-cell fusion 1. Ann Rev Cell and Dev Biol 12 (1): 627-661.
35. Chan DC, Kim PS, (1998) HIV entry and its inhibition. Cell 93 (5): 681-684.
36. Johnson PR, Olmsted RA, Prince GA, Murphy BR, Alling DW, et al. (1987) Antigenic relatedness between glycoproteins of human respiratory syncytial virus subgroups A and B: evaluation of the contributions of F and G glycoproteins to immunity. J Virol 61 (10): 3163-3166.
37. Cane PA, (1997) Analysis of linear epitopes recognised by the primary human antibody response to a variable region of the attachment (G) protein of respiratory syncytial virus. J Med Virol 51 (4): 297-304.
38. Palomo C, Cane PA, Melero JA, (2000) Evaluation of the antibody specificities of human convalescent-phase sera against the attachment (G) protein of human respiratory syncytial virus: Influence of strain variation and carbohydrate side chains. J Med Virol 60 (4): 468-474.
39. Johnson PR, Spriggs MK, Olmsted RA, Collins PL, (1987) The G glycoprotein of human respiratory syncytial viruses of subgroups A and B: extensive sequence divergence between antigenically related proteins. Proc Nat Acad Sci USA 84 (16): 5625-5629.
40. Ishiguro N, Ebihara T, Endo R, Ma X, Kikuta H, et al. (2004) High genetic diversity of the attachment (G) protein of human metapneumovirus. J Clin Microbiol 42 (8): 3406-3414.
41. MacArthur WM, Thornton JM, (1991) Influence of proline residues on protein conformation. Journal of Molecular Biology 218 (2): 397-412.
42. Wertz GW, Collins PL, Huang Y, Gruber C, Levine S, et al. (1985) Nucleotide sequence of the G protein gene of human respiratory syncytial virus reveals an unusual type of viral membrane protein. Proc Nat Acad Sci USA 82 (12): 4075-4079.
43. Botosso VF, Zanotto PMde A, Ueda M, Arruda E, Gilio AE, et al. (2009) Positive selection results in frequent reversible amino acid replacements in the G protein gene of human respiratory syncytial virus. PLoS Pathog 5 (1): e1000254.
44. Langedijk JPM, Schaaper WMM, Meloen RH, van Oirschot JT, (1996) Proposed three-dimensional model for the attachment protein G of respiratory syncytial virus. J Gen Virol 77 (6): 1249-1257.
45. Melero JA, Garcia-Barreno B, Martinez I, Pringle CR, Cane PA, (1997) Antigenic structure, evolution and immunobiology of human respiratory syncytial virus attachment (G) protein. J Gen Virol 78 (10): 2411-2418.
46. Feldman SA, Hendry RM, Beeler JA, (1999) Identification of a linear heparin binding domain for human respiratory syncytial virus attachment glycoprotein G. J Virol 73 (8): 6610-6617.
47. Lerch RA, Anderson K, Wertz GW, (1990) Nucleotide sequence analysis and expression from recombinant vectors demonstrate that the attachment protein G of bovine respiratory syncytial virus is distinct from that of human respiratory syncytial virus. J Virol 64 (11): 5559-5569.
48. Tripp RA, Jones LP, Haynes LM, Zheng H, Murphy PM, et al. (2001) CX3C chemokine mimicry by respiratory syncytial virus G glycoprotein. Nat Immunol 2 (8): 732-8.
49. Murata Y, Lightfoote PM, Falsey AR, Walsh EE, (2010) Identification and human serum reactogenicity of neutralizing epitopes within the central unglycosylated region of the respiratory syncytial virus attachment protein. Clin Vacc Immunol 17 (4): 695-7.
50. Biacchesi S, Skiadopoulos MH, Boivin G, Hanson CT, Murphy BR, et al. (2003) Genetic diversity between human metapneumovirus subgroups. Virology 315 (1): 1-9.
51. Peret TCT, Abed Y, Anderson LJ, Erdman DD, Boivin G, (2004) Sequence polymorphism of the predicted human metapneumovirus G glycoprotein. J Gen Virol 85 (3): 679-686.
52. Bukreyev A, Yang L, Fricke J, Cheng L, Ward JM, et al. (2008) The secreted form of the G glycoprotein of respiratory syncytial virus helps the virus evade antibody-mediated restriction of replication by acting as an antigen decoy and through effects on Fc receptor-bearing leukocytes. J Virol pp. JVI.01604-08.
53. Scott PD, Ochola R, Ngama M, Okiro EA, Nokes D, et al. (2006) Molecular analysis of respiratory syncytial virus reinfections in infants from coastal Kenya. J Inf Dis 193 (1): 59-67.
54. White LJ, Waris M, Cane PA, Nokes DJ, Medley GF, (2005) The transmission dynamics of groups A and B human respiratory syncytial virus (hRSV) in England & Wales and Finland: seasonality and cross-protection. Epidemiol Infect 133 (2): 279-89.
55. Reitter JN, Means RE, Desrosiers RC, (1998) A role for carbohydrates in immune evasion in AIDS. Nat Med 4 (6): 679-84.
56. de Graaf M, Osterhaus ADME, Fouchier RAM, Holmes EC, (2008) Evolutionary dynamics of human and avian metapneumoviruses. J Gen Virol 89 (12): 2933-2942.
57. Padhi A, Verghese B, (2008) Positive natural selection in the evolution of human metapneumovirus attachment glycoprotein. Virus Res 131 (2): 121-131.
58. Yang CF, Wang C, Tollefson S, Piyaratna R, Lintao L, et al. (2009) Genetic diversity and evolution of human metapneumovirus fusion protein over twenty years. Virol J 6 (1): 138.
59. Drummond A, Rambaut A, (2007) BEAST: Bayesian evolutionary analysis by sampling trees. BMC Evol Biol 7 (1): 214.
60. McWilliam Leitch EC, Cabrerizo M, Cardosa J, Harvala H, Ivanova OE, et al. (2010) Evolutionary dynamics and temporal/geographical correlates of recombination in the human enteroviruses, echovirus 9, 11 and 30. J Virol pp. JVI.00783-10.
61. Zhang C, Mammen MP Jr, Chinnawirotpisan P, Klungthong C, Rodpradit P, et al. (2005) Clade replacements in dengue virus serotypes 1 and 3 are associated with changing serotype prevalence. J Virol 79 (24): 15123-15130.
62. Santibanez S, Tischer A, Heider A, Siedler A, Hengel H, (2002) Rapid replacement of endemic measles virus genotypes. J Gen Virol 83 (11): 2699-2708.
63. Garcia O, Martin M, Dopazo J, Arbiza J, Frabasile S, et al. (1994) Evolutionary pattern of human respiratory syncytial virus (subgroup A): cocirculating lineages and correlation of genetic and antigenic changes in the G glycoprotein. J Virol 68 (9): 5448-5459.
64. Sullender WM, Mufson MA, Anderson LJ, Wertz GW, (1991) Genetic diversity of the attachment protein of subgroup B respiratory syncytial viruses. J Virol 65 (10): 5425-5434.
65. Sullender WM, Mufson MA, Prince GA, Anderson LJ, Wertz GW, (1998) Antigenic and genetic diversity among the attachment proteins of group A respiratory syncytial viruses that have caused repeat infections in children. J Inf Dis 178 (4): 925-932.
66. Woelk CH, Holmes EC, (2001) Variable immune-driven natural selection in the attachment (G) glycoprotein of respiratory syncytial virus (RSV). J Mol Evol 52 (2): 182-192.
67. Lopez JA, Andreu D, Carreno C, Whyte P, Taylor G, et al. (1993) Conformational constraints of conserved neutralizing epitopes from a major antigenic area of human respiratory syncytial virus fusion glycoprotein. J Gen Virol 74 (12): 2567-2577.
68. Cane PA, Pringle CR, (1995) Evolution of subgroup A respiratory syncytial virus: evidence for progressive accumulation of amino acid changes in the attachment protein. J Virol 69 (5): 2918-2925.
69. Martinez I, Dopazo J, Melero JA, (1997) Antigenic structure of the human respiratory syncytial virus G glycoprotein and relevance of hypermutation events for the generation of antigenic variants. J Gen Virol 78 (10): 2419-2429.
70. Walsh EE, Falsey AR, Sullender WM, (1998) Monoclonal antibody neutralization escape mutants of respiratory syncytial virus with unique alterations in the attachment (G) protein. J Gen Virol 79 (3): 479-487.
71. Garcia-Barreno B, Portela A, Delgado T, Lopez JA, Melero JA, (1990) Frame shift mutations as a novel mechanism for the generation of neutralization resistant mutants of human respiratory syncytial virus. EMBO J pp. 4181-4187.
72. Olmsted RA, Murphy BR, Lawrence LA, Elango N, Moss B, et al. (1989) Processing, surface expression, and immunogenicity of carboxy-terminally truncated mutants of G protein of human respiratory syncytial virus. J Virol 63 (1): 411-420.
73. Rueda P, Palomo CN, Garcia-Barreno B, Melero JA, (1995) The three C-terminal residues of human respiratory syncytial virus G glycoprotein (Long strain) are essential for integrity of multiple epitopes distinguishable by antiidiotypic antibodies. Viral Immunol 8 (1): 37-46.
74. Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ, (2001) Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein. J Biol Chem 276 (42): 38988-38994.
75. Martinez I, Valdes O, Delfraro A, Arbiza J, Russi J, et al. (1999) Evolutionary pattern of the G glycoprotein of human respiratory syncytial viruses from antigenic group B: the use of alternative termination codons and lineage diversification. J Gen Virol 80 (1): 125-130.
76. Herd KA, Mahalingam S, Mackay IM, Nissen M, Sloots TP, et al. (2006) Cytotoxic T-lymphocyte epitope vaccination protects against human metapneumovirus infection and disease in mice. J Virol 80 (4): 2034-2044.
77. Boivin G, Mackay I, Sloots TP, Madhi S, Freymuth F, et al. (2004) Global genetic diversity of human metapneumovirus fusion gene. Emerg Inf Dis 10 (6): 1154-7.
78. Chieochansin T, Samransamruajkit R, Chutinimitkul S, Payungporn S, Hiranras T, et al. (2008) Human bocavirus (HBoV) in Thailand: clinical manifestations in a hospitalized pediatric patient and molecular virus characterization. J Infect 56 (2): 137-142.
79. Yang Z, Wong WSW, Nielsen R, (2005) Bayes empirical Bayes inference of amino acid sites under positive selection. Mol Biol Evol 22 (4): 1107-1118.